OVID Chart
- 52-Week Range: $1.96 - $4.49
- Market Capitalization: $145.06M
- Short Percentage: 0%
- Target Price: $5.50
- Shares Outstanding: 70.42M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
OVID released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Ovid Therapeutics Reports First Quarter 2022 Financial Results and Corporate HighlightsGlobeNewsWire | May 10th
- Ovid Therapeutics to Present at the 21st Annual Needham Virtual Healthcare ConferenceGlobeNewsWire | April 8th
- Ovid Therapeutics Reports Business Update, Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewsWire | March 15th
- Ovid Therapeutics to Participate at the Cowen 42nd Annual Health Care ConferenceGlobeNewsWire | March 4th
- Ovid Therapeutics Expands Epilepsy Franchise with Novel KCC2 ActivatorsGlobeNewsWire | January 3rd
- Ovid Therapeutics Reports Third Quarter 2021 Business Update, Corporate Highlights and Financial ResultsGlobeNewsWire | November 10th
- Ovid Therapeutics Appoints Dr. Kevin Fitzgerald to Board of DirectorsGlobeNewsWire | October 7th
- Ovid Therapeutics Reports Second Quarter 2021 Financial Results and Corporate HighlightsGlobeNewsWire | August 16th
- Ovid Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare ConferenceGlobeNewsWire | July 7th
Company Info
Website: https://www.ovidrx.com
Address: 1460 Broadway, New York, NY, United States, 10036
Sector: Healthcare
Industry: Biotechnology
Full time employees: 57
Address: 1460 Broadway, New York, NY, United States, 10036
Sector: Healthcare
Industry: Biotechnology
Full time employees: 57
$OVID let’s gooooo
$OVID Momentum is building...
$OVID down hard at open
$OVID Looks like a solid reversal - retesting support right now
definitely thinking about swinging this
$OVID Of course
$OVID let’s buy NOW!!!
$OVID green monday